z-logo
Premium
Electrocardiographic findings in mdx mice: A cardiac phenotype of Duchenne muscular dystrophy
Author(s) -
Chu Victor,
Otero Jose M.,
Lopez Orlando,
Sullivan Matthew F.,
Morgan James P.,
Amende Ivo,
Hampton Thomas G.
Publication year - 2002
Publication title -
muscle and nerve
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 145
eISSN - 1097-4598
pISSN - 0148-639X
DOI - 10.1002/mus.10223
Subject(s) - duchenne muscular dystrophy , mdx mouse , medicine , heart rate , atropine , muscular dystrophy , dystrophin , endocrinology , autonomic nervous system , qt interval , cardiology , tachycardia , blood pressure
The mdx mouse is a model of Duchenne muscular dystrophy (DMD). As many DMD patients die of cardiac failure, we investigated whether mdx mice exhibited clinically relevant cardiac phenotypes. We applied a recently developed method for noninvasively recording electrocardiograms (ECGs) to study male mdx mice ( n = 15) and control mice ( n = 15). The mdx mice had significant tachycardia and decreased heart rate variability, consistent with observations in DMD patients. Heart rate was nearly 15% faster in mdx mice than control mice ( P < 0.05). The rate‐corrected QT interval duration and PR interval were shorter in mdx compared to control mice ( P < 0.05). The muscarinic antagonist atropine significantly increased heart rate and decreased PR interval in C57 mice. In contrast, atropine significantly decreased heart rate and increased PR interval in all mdx mice. Pharmacological autonomic blockade and baroreflex sensitivity testing demonstrated an imbalance in autonomic nervous system modulation of heart rate, with decreased parasympathetic activity and increased sympathetic activity in mdx mice. Baseline ECGs and contrary responses to muscarinic blockade by atropine in mice deficient in neuronal nitric oxide synthase (nNOS) suggest that the autonomic dysfunction in mdx mice may be independent of decreased myocardial nNOS. These electrocardiographic findings in dystrophin‐deficient mice may provide new bases for diagnosing, understanding, and treating DMD patients. © 2002 Wiley Periodicals, Inc. Muscle Nerve 26: 513–519, 2002

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here